Composition for modifying conformation of Src kinase, useful for treating e.g. cancer or osteoporosis, comprises a compound with proline-rich C-terminus

摘要

Pharmaceutical composition for inducing conformational modification of Src protein comprises at least one agent (I) containing a C-terminus rich in proline, optionally also a carrier.